DNA DAY SPECIAL SALE! 65% Off + Free Shipping

Decoding the Mysteries of Short-Rib Thoracic Dysplasia 10 with Polydactyly: Understanding, Diagnosis, and Genetic Testing

Short-rib thoracic dysplasia 10 with polydactyly

Expert Reviewed By: Dr. Brandon Colby MD

Short-rib thoracic dysplasia 10 with polydactyly (SRTD10) is a rare genetic disorder characterized by skeletal abnormalities, including shortened ribs and limbs, as well as extra fingers or toes. This condition can be life-threatening, and early diagnosis is crucial for appropriate management and treatment. In this article, we will explore the clinical and genetic characteristics of SRTD10, the importance of genetic testing, and how it can be beneficial for affected individuals and their families.

Understanding Short-Rib Thoracic Dysplasia 10 with Polydactyly

SRTD10 is a type of skeletal ciliopathy, a group of genetic disorders that affect the structure and function of cilia, which are hair-like structures on the surface of cells. These cilia play a crucial role in various cellular processes, including cell signaling and organ development. Dysfunction of cilia can lead to a wide range of health problems, including skeletal, respiratory, and neurological abnormalities.

Several genes have been implicated in the development of SRTD10, including DYNC2H1 and KIAA0586. Mutations in these genes can lead to the production of abnormal proteins, which in turn disrupt the normal functioning of cilia and cause the characteristic features of SRTD10.

Diagnosing Short-Rib Thoracic Dysplasia 10 with Polydactyly

Diagnosis of SRTD10 typically involves a combination of clinical examination, imaging studies, and genetic testing. Clinical examination may reveal characteristic features such as short limbs, narrow chest, and polydactyly. Imaging studies, such as X-rays and ultrasounds, can provide further evidence of skeletal abnormalities.

However, definitive diagnosis often requires genetic testing to identify the specific gene mutations responsible for the condition. Whole-exome sequencing (WES) is a powerful tool that can analyze all protein-coding regions of an individual’s DNA, allowing for the identification of disease-causing mutations.

Genetic Testing for SRTD10: Identifying the Culprit Mutations

Several studies have demonstrated the value of genetic testing in diagnosing SRTD10 and understanding its underlying genetic causes. For example, a study examining the clinical and genetic characteristics of Russian patients with SRTD10 found that mutations in the DYNC2H1 gene were a common cause of the disorder. Similarly, research involving four Chinese families affected by SRTD10 identified compound heterozygous variants of the DYNC2H1 gene as the cause of the condition.

Another study investigated a fetus with short limbs and polydactyly, discovering compound heterozygous pathogenic variants in the KIAA0586 gene through exome sequencing. These findings highlight the importance of genetic testing in identifying the specific gene mutations responsible for SRTD10 and providing accurate diagnoses.

Benefits of Genetic Testing for SRTD10: Prenatal Diagnosis and Genetic Counseling

Genetic testing for SRTD10 has several practical applications, including prenatal diagnosis and genetic counseling. Prenatal diagnosis can help identify fetuses affected by SRTD10, allowing for appropriate management and potentially life-saving interventions. Moreover, genetic counseling can provide valuable information to families affected by SRTD10, helping them understand the risks and implications of the condition and make informed decisions about future pregnancies.

For instance, a study identifying two compound heterozygous variations in the DYNC2H1 gene causing SRTD10 provided guidance for future pregnancies and highlighted the value of WES in diagnosis. Similarly, the study involving the fetus with KIAA0586 mutations demonstrated the utility of exome sequencing in prenatal diagnosis and informed decision-making for the affected family.

Conclusion

Short-rib thoracic dysplasia 10 with polydactyly is a rare and complex genetic disorder with potentially life-threatening consequences. Genetic testing, particularly whole-exome sequencing, has proven invaluable in diagnosing SRTD10 and identifying the specific gene mutations responsible for the condition. Furthermore, genetic testing can facilitate prenatal diagnosis and provide essential information for genetic counseling, enabling affected families to make informed decisions about their future.

About The Expert Reviewer

Dr. Brandon Colby MD is a US physician specializing in the personalized prevention of disease through the use of genomic technologies. He’s an expert in genetic testing, genetic analysis, and precision medicine. Dr. Colby is also the Founder of  and the author of ⁠⁠Outsmart Your Genes.

Dr. Colby holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University’s Graduate School of Business, and a degree in Genetics with Honors from the University of Michigan. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (⁠⁠ACMG), an Associate of the American College of Preventive Medicine (⁠⁠ACPM), and a member of the National Society of Genetic Counselors (⁠NSGC)

© 2025 Sequencing.com